Safety and efficacy of acellular pertussis vaccines: the Mainz study and other recent studies.
JA Weigl, HL Bock, R Clemens, F Zepp… - Annals of the …, 1997 - europepmc.org
Following concerns about the safety and reactogenicity profile of diphtheria, tetanus and
whole cell pertussis vaccines (DTwP), new and less reactogenic alternatives were …
whole cell pertussis vaccines (DTwP), new and less reactogenic alternatives were …
[PDF][PDF] Study of pertussis vaccines in infants: Comparison of response to acellular pertussis DTP vaccines containing 25 μg of FHA and either 25 or 8 μg of
H Vanura, M Just, F Ambrosch, RM Berger, H Bogaerts… - Vaccine, 1994 - academia.edu
Clinical and serological responses of infants to primary vaccination with diphtheriatetanus-
acellular pertussis (DTPa) vaccines containing 25# g of filamentous haemagglutinin (FHA) …
acellular pertussis (DTPa) vaccines containing 25# g of filamentous haemagglutinin (FHA) …
Adverse effects and sero-responses to an acellular pertussis/diphtheria/tetanus vaccine when combined with Haemophilus influenzae type b vaccine in an …
F Bell, P Heath, J MacLennan, F Shackley… - European journal of …, 1999 - Springer
Acellular pertussis vaccines provide protection against pertussis with few adverse effects.
Differences in the reactogenicity and immunogenicity of available pertussis vaccines may be …
Differences in the reactogenicity and immunogenicity of available pertussis vaccines may be …
Acellular pertussis vaccine as a booster dose for seventeen-to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four …
SA Halperin, E Mills, L Barreto, C Pim… - The Pediatric …, 1995 - journals.lww.com
The safety and immunogenicity of two formulations of an acellular pertussis vaccine as a
booster at 17 to 19 months of age were assessed in children immunized at 2, 4 and 6 …
booster at 17 to 19 months of age were assessed in children immunized at 2, 4 and 6 …
Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy
Background: In clinical trials, diphtheria, tetanus and acellular pertussis vaccines have been
shown to be less reactogenic than whole-cell combination vaccines. Aim: To evaluate …
shown to be less reactogenic than whole-cell combination vaccines. Aim: To evaluate …
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine
S Lugauer, U Heininger, JD Cherry, K Stehr - European journal of …, 2002 - Springer
The objective of this open study was to monitor the long-term effectiveness of the Lederle-
Takeda diphtheria and tetanus toxoids and acellular pertussis antigen (s)(DTaP) vaccine …
Takeda diphtheria and tetanus toxoids and acellular pertussis antigen (s)(DTaP) vaccine …
Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers
Sustained high incidence of pertussis, particularly amongst unvaccinated infants, is of
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …
Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination …
E Mallet, N Matisse, N Mathieu, J Langue, F Boisnard… - Vaccine, 2004 - Elsevier
The main objective of this study was to assess in 5–6-year-old French children (n= 234) the
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
persistence of antibodies induced by a primary series vaccination (at 2–4 months of age) …
A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults
FM Turnbull, TC Heath, BB Jalaludin, MA Burgess… - Vaccine, 2000 - Elsevier
A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …